Article Information
History
- April 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anders Lundin1,†,*,
- Michelle J. Porritt1,†,*,
- Himjyot Jaiswal1,8,
- Frank Seeliger2,
- Camilla Johansson3,
- Abdel Wahad Bidar3,
- Lukas Badertscher1,
- Emma J. Davies4,9,
- Elizabeth Hardaker4,
- Carla P. Martins4,
- Therese Admyre1,
- Amir Taheri-Ghahfarokhi1,
- Jenna Bradley5,
- Anna Schantz6,
- Babak Alaeimahabadi7,
- Maryam Clausen1,
- Xiufeng Xu1,
- Lorenz M. Mayr1,
- Roberto Nitsch1,
- Mohammad Bohlooly-Y1,
- Simon T. Barry4 and
- Marcello Maresca1,*
- 1Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 2Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 3Clinical Pharmacology & Safety Sciences, Sweden Imaging Hub, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 4Early Oncology TDE, Oncology R&D, AstraZeneca, Li KaShing Centre, Cambridge, UK
- 5Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge Science Park, Cambridge, UK
- 6Pharmaceutical Sciences, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 7Data Sciences & Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 8Cellink AB, Gothenburg, Sweden
- 9Healx, Cambridge, UK
- ↵*Corresponding author, Correspondence to: Marcello Maresca, Translational Genomics, Discovery Sciences, AstraZeneca, Pepparedsleden 1, Mölndal 43 183, Sweden, Phone: +46 31 776 1364, email: Marcello.Maresca{at}astrazeneca.com
↵† These authors contributed equally to this work